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Deceptive access promoted by leading neu‑
rologists harms patients
To the editor  The case described by Musiałek 
et al1 in the April issue of Kardiologia Polska (Kar-
diol Pol, Polish Heart Journal) shows ineffective 
treatment of a patient with stroke. It illustrates 
the incorrect, from the public health standpoint, 
implementation of new technology. Thrombo‑
lytic therapy helps to dissolve the clot clogging 
the vessel and improves blood flow in 25% of the 
patients with ischemic stroke. However, intra‑
cranial bleeding is not a rare complication. Sta‑
tistical data confirm that early thrombolysis 
is beneficial for the population, but it is rather 
a gambling game for an individual patient. Some 
neurologists, fascinated by the results of clini‑
cal trials, promote thrombolysis, while others, 
mainly caring for patients in practice, are more 
restrained in offering treatment that relatively 
often transforms mild ischemic stroke into large 
hemorrhagic stroke. After many years of promo‑
tion, thrombolysis is still far from widespread 
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the country. This problem could be solved if de‑
cision makers were ready to think openly.5 We 
have more than 150 cardiac centers performing 
coronary interventions with teams working on‑
‑site 24/7/365. They have a sufficient number of 
very experienced interventionists. If one‑third of 
them became additionally MT centers, we could 
cure the current illogical and unethical system, 
which violates the main Hippocratic principle: 
“first do no harm.”
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use. Recently, a new breakthrough technology 
has become available—a mechanical retriever 
of a clot from the occluded vessel (mechanical 
thrombectomy [MT]). Compared with thrombol‑
ysis, it is much more effective and causes fewer 
complications.2 However, it has a disadvantage: it 
cannot be used by neurologists in stroke centers.
Musiałek et al1 described the case of a pa‑
tient who was qualified for transfer to a neuro‑
radiological center (comprehensive stroke center 
[CSC]) after the diagnosis of middle cerebral ar‑
tery blockage and finding contraindications for 
thrombolysis. However, the CSC refused to ad‑
mit the patient arguing that it would be “too late 
for treatment.” Was it necessary to waste time 
in a local hospital? The scheme of care for the 
patient with stroke in Poland requires “throm‑
bolysis first” and only if there is no clinical im‑
provement, transfer for endovascular treatment 
is suggested. This usually causes a much lon‑
ger delay than in the case of contraindications 
for lysis. Time ‑consuming transport and inef‑
fective alteplase usually move patients out of 
the time window for MT treatment. Every min‑
ute counts for saving the brain, so the obvious 
rule should be “most effective treatment first.” 
There is strong scientific evidence that the ben‑
efit of MT is greater than that of fibrinolysis,3 
except when MT is associated with significant 
waiting time for the procedure. This means that 
an ambulance should directly go to MT centers 
from most parts of the country. It is necessary 
to identify areas away from MT centers, from 
which transfer to a local stroke unit for throm‑
bolysis could be an appropriate option.4
Certain relevant details of the case described 
by Musiałek et al1 should be noted. The patient 
was referred to the CSC on Sunday, late at night. 
It is reasonable to doubt whether the reason for 
refusal was the time window for MT treatment 
or rather lack of readiness for midnight cathe‑
terization. The center needs an experienced in‑
terventionist ready to work 24/7/365 on ‑site. It 
means that 4 to 5 operators should be engaged. 
To overcome the shortage of interventionists, 
some centers organize them on ‑call instead of 
on ‑site. Probably, this was the real reason for re‑
fusal. Problems with availability of operators on 
duty easily explain what happened in that case.
The idea to carry out MT exclusively in neu‑
roradiological CSCs has 3 main disadvantages. 
First, neuroradiological procedures for aneu‑
rysms and malformations are not so common 
and it is not economically reasonable to keep 
CSCs on 24/7/365 duty. Even the addition of 
the currently small number of patients requir‑
ing MT will not make these centers economical‑
ly efficient. Second, CSCs have few intervention‑
ists, usually 1 or 2—too few to arrange 24‑hour 
on ‑site service. Third, there is a small number of 
CSCs, so it is not possible to provide MT in suit‑
able, short time in patients from most areas of 
